Atlas Trials

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Clinical trial NCT00143364 · COMPLETED

Trial details

NCT number
NCT00143364
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2003-06-01
Enrollment
1005

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.